Cargando…
The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
BACKGROUND: There is growing concern regarding the increased incidence of bladder cancer in diabetic patients using pioglitazone. This study aimed to investigate the association between bladder cancer and the use of pioglitazone in Korean diabetics. METHODS: This retrospective, matched case-control...
Autores principales: | Song, Sun Ok, Kim, Kwang Joon, Lee, Byung-Wan, Kang, Eun Seok, Cha, Bong Soo, Lee, Hyun Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486984/ https://www.ncbi.nlm.nih.gov/pubmed/23130322 http://dx.doi.org/10.4093/dmj.2012.36.5.371 |
Ejemplares similares
-
Response: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
por: Kim, Kwang Joon, et al.
Publicado: (2013) -
Response: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
por: Song, Sun Ok, et al.
Publicado: (2012) -
Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients
por: Lee, Young Ki, et al.
Publicado: (2013) -
Tolerability, effectiveness and predictive parameters for the therapeutic usefulness of exenatide in obese, Korean patients with type 2 diabetes
por: Song, Sun Ok, et al.
Publicado: (2013) -
Postprandial Triglyceride Is Associated with Fasting Triglyceride and HOMA-IR in Korean Subjects with Type 2 Diabetes
por: Lee, Seo Hee, et al.
Publicado: (2011)